JP2023539368A5 - - Google Patents
Info
- Publication number
- JP2023539368A5 JP2023539368A5 JP2023514414A JP2023514414A JP2023539368A5 JP 2023539368 A5 JP2023539368 A5 JP 2023539368A5 JP 2023514414 A JP2023514414 A JP 2023514414A JP 2023514414 A JP2023514414 A JP 2023514414A JP 2023539368 A5 JP2023539368 A5 JP 2023539368A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleotide sequence
- seq
- sequence
- nucleic acid
- vector
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063073843P | 2020-09-02 | 2020-09-02 | |
| US63/073,843 | 2020-09-02 | ||
| PCT/US2021/048267 WO2022051232A1 (en) | 2020-09-02 | 2021-08-30 | Codon optimized rpgrorf 15 genes and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023539368A JP2023539368A (ja) | 2023-09-13 |
| JP2023539368A5 true JP2023539368A5 (cg-RX-API-DMAC7.html) | 2024-09-06 |
Family
ID=80358240
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023514414A Pending JP2023539368A (ja) | 2020-09-02 | 2021-08-30 | コドン最適化したrpgrorf15遺伝子およびその使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US20230340042A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4208156A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2023539368A (cg-RX-API-DMAC7.html) |
| KR (1) | KR102825852B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN116782886A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021337530B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112023003834A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3191540A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL300785B2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022051232A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3191540A1 (en) * | 2020-09-02 | 2022-03-10 | 4D Molecular Therapeutics Inc. | Codon optimized rpgrorf 15 genes and uses thereof |
| CN117165596A (zh) * | 2022-05-27 | 2023-12-05 | 武汉纽福斯生物科技有限公司 | 编码rpgr的核酸及其应用 |
| CN121263322A (zh) | 2023-05-11 | 2026-01-02 | 株式会社Lg新能源 | 用于提供与自主驾驶相关的能量管理服务的计算系统、计算系统的操作方法及车辆 |
| AU2024315073A1 (en) * | 2023-07-28 | 2026-01-22 | Regeneron Pharmaceuticals, Inc. | Use of bgh-sv40l tandem polya to enhance transgene expression during unidirectional gene insertion |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002326961A1 (en) * | 2001-10-10 | 2003-04-22 | Centocor, Inc. | Nucleic acid vaccines using tumor antigen encoding nucleic acids with cytokine adjuvant encoding nucleic acid |
| US9163259B2 (en) * | 2012-05-04 | 2015-10-20 | Novartis Ag | Viral vectors for the treatment of retinal dystrophy |
| CN105120901A (zh) * | 2012-07-11 | 2015-12-02 | 宾夕法尼亚大学托管会 | Rpgr x染色体连锁视网膜退化的aav介导的基因治疗 |
| EP3132051B1 (en) | 2014-04-15 | 2019-03-20 | Applied Genetic Technologies Corporation | Codon optimized nucleic acid encoding a retinitis pigmentosa gtpase regulator (rpgr) |
| GB201516066D0 (en) * | 2015-09-10 | 2015-10-28 | Young & Co Llp D | Treatment of retinitis pigmentosa |
| WO2017197355A2 (en) * | 2016-05-13 | 2017-11-16 | 4D Molecular Therapeutics Inc. | Adeno-associated virus variant capsids and methods of use thereof |
| GB201704192D0 (en) * | 2017-03-16 | 2017-05-03 | Nightstarx Ltd | Treatment of Retinitis Pigmentosa |
| TW202028225A (zh) | 2018-09-21 | 2020-08-01 | 英商夜星克有限公司 | 用於治療色素性視網膜炎之組合物及方法 |
| CN113952472A (zh) * | 2020-07-21 | 2022-01-21 | 英斯培瑞有限公司 | 用于治疗眼部疾病的组合物和方法 |
| CA3191540A1 (en) * | 2020-09-02 | 2022-03-10 | 4D Molecular Therapeutics Inc. | Codon optimized rpgrorf 15 genes and uses thereof |
-
2021
- 2021-08-30 CA CA3191540A patent/CA3191540A1/en active Pending
- 2021-08-30 IL IL300785A patent/IL300785B2/en unknown
- 2021-08-30 BR BR112023003834A patent/BR112023003834A2/pt unknown
- 2021-08-30 EP EP21864959.8A patent/EP4208156A4/en not_active Withdrawn
- 2021-08-30 AU AU2021337530A patent/AU2021337530B2/en active Active
- 2021-08-30 JP JP2023514414A patent/JP2023539368A/ja active Pending
- 2021-08-30 CN CN202180072680.6A patent/CN116782886A/zh active Pending
- 2021-08-30 WO PCT/US2021/048267 patent/WO2022051232A1/en not_active Ceased
- 2021-08-30 US US18/042,517 patent/US20230340042A1/en not_active Abandoned
- 2021-08-30 KR KR1020237007137A patent/KR102825852B1/ko active Active
- 2021-08-30 US US17/461,716 patent/US11345930B2/en active Active
-
2022
- 2022-05-26 US US17/825,665 patent/US20220290181A1/en not_active Abandoned